Contents
Academic literature on the topic 'BMQ-Specific'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'BMQ-Specific.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "BMQ-Specific"
1
Salgado, Teresa, Alexandra Marques, Leonor Geraldes, Shalom Benrimoj, Robert Horne, and Fernando Fernandez-Llimos. "Cross-cultural adaptation of the Beliefs about Medicines Questionnaire into Portuguese." Sao Paulo Medical Journal 131, no. 2 (2013): 88–94. http://dx.doi.org/10.1590/s1516-31802013000100018.
Full textAbstract:
CONTEXT AND OBJECTIVES The Beliefs about Medicines Questionnaire (BMQ-Specific) has proven useful for measuring patients' beliefs and associating them with non-adherence to treatment in several illness groups. The aim was to cross-culturally adapt the BMQ-Specific into Portuguese for the general population of medicine users. DESIGN AND SETTING Cross-sectional study conducted among users of public hospitals and outpatient clinics in Guarda and Covilhã, Portugal. METHODS The BMQ-Specific was translated using international recommendations for performing cross-cultural adaptation and was administered to 300 patients. An initial principal component analysis (PCA) was conducted with the extraction criterion of eigenvalue > 1.0, followed by a second PCA with restriction to two components. Reliability was assessed by calculating Cronbach's alpha coefficient. RESULTS The mean scores obtained for the Necessity and Concerns subscales of the Portuguese BMQ-Specific were 19.9 (standard deviation, SD = 2.8) (range 10 to 25) and 17.7 (SD = 3.9) (range 6 to 30), respectively. The first PCA produced an unstable three-component structure for the Portuguese BMQ-Specific. The final PCA solution yielded a two-component structure identical to the original English version (a five-item Necessity and a six-item Concerns subscale), and explained 44% of the variance. Cronbach's alpha for the complete Portuguese BMQ-Specific was 0.70, and 0.76 and 0.67 for the Necessity and Concerns subscales, respectively. CONCLUSION A cross-culturally adapted Portuguese version of the BMQ-Specific questionnaire for use among the general population of medicine users was obtained, presenting good internal consistency and component structure identical to the original English version.
2
Jimenez, Krystal, Cristina Vargas, Karla Garcia, Herlinda Guzman, Marco Angulo, and John Billimek. "Evaluating the Validity and Reliability of the Beliefs About Medicines Questionnaire in Low-Income, Spanish-Speaking Patients With Diabetes in the United States." Diabetes Educator 43, no. 1 (2016): 114–24. http://dx.doi.org/10.1177/0145721716675740.
Full textAbstract:
Purpose The purpose of this study was to examine the reliability and validity of a Spanish version of the Beliefs about Medicines Questionnaire (BMQ) as a measure to evaluate beliefs about medications and to differentiate adherent from nonadherent patients among low-income Latino patients with diabetes in the United States. Methods Seventy-three patients were administered the BMQ and surveyed for evidence of medication nonadherence. Internal consistency of the BMQ was assessed by Cronbach’s alpha along with performing a confirmatory factor analysis. Criterion validity was assessed by comparing mean scores on 3 subscales of the BMQ (General Overuse, General Harm, and Specific Necessity–Concerns difference score) between adherent patients and patients reporting nonadherence for 3 different reasons (unintentional nonadherence, cost-related nonadherence, and nonadherence due to reasons other than cost) using independent samples t tests. Results The BMQ is a reliable instrument to examine beliefs about medications in this Spanish-speaking population. Construct validity testing shows nearly identical factor loading as the original construct map. General Overuse scores were significantly more negative for patients reporting each reason for nonadherence compared with their adherent counterparts. Necessity–Concerns difference scores were significantly more negative for patients reporting nonadherence for reasons other than cost compared with those who did not report this reason for nonadherence. Conclusion The Spanish version of the BMQ is appropriate to assess beliefs about medications in Latino patients with type 2 diabetes in the United States and may help identify patients who become nonadherent to medications for reasons other than out-of-pocket costs.
3
Veenstra, F., J. Vriezekolk, H. J. Schers, N. Van Herwaarden, B. Van den Bemt, and M. Flendrie. "AB0634 BELIEFS ABOUT URATE LOWERING THERAPY DIFFER BETWEEN GENERAL PRACTITIONERS AND RHEUMATOLOGISTS." Annals of the Rheumatic Diseases 80, Suppl 1 (2021): 1351.1–1351. http://dx.doi.org/10.1136/annrheumdis-2021-eular.1834.
Full textAbstract:
Background:Uric acid lowering therapy (ULT) can be effective in gout if taken correctly (1), but non-adherence is a known problem (2). Although patients’ adherence barriers regarding ULT, such as lack of knowledge on disease and therapy, and beliefs, have been widely studied (3), less is known physicians’ beliefs.Objectives:To investigate the physicians’ beliefs on ULT treatment in both primary and secondary care in the Netherlands.Methods:Cross-sectional study among all rheumatologists of the Sint Maartenskliniek and to all General Practitioners (GPs) of 17 practices, participating in the practice-based research network Family Medicine Network Nijmegen, Netherlands. All participants filled out the beliefs about medication questionnaire (BMQ), adjusted for physicians; in addition data were collected on physician characteristics including working experience in total and gout consultations. The BMQ consists of two parts, a specific part with 10 questions about beliefs on necessity (N=5) and concerns (N=5) regarding ULT and a general part with 8 questions about beliefs on harms (N=4) and overuse (N=4) regarding medication in general. Each question is scored on a Likert-scale from 1-5, a higher score corresponds to higher beliefs on that category. Sum scores for all four categories were calculated. With the total scores on the specific BMQ including necessity and concerns beliefs, physicians were classified in four different categories (Table 1)(4).Results:In total 112 physicians received the questionnaire, 28 of 37 rheumatologists (76%) and 45 of 75 GPs (60%) responded. Rheumatologists had less years of experience than GPs (median 8.5 years (IQR 3 – 14) versus (vs) 13 years (IQR 8-20)) and less hours of patient contact per week (15 hours (IQR 8.5 – 20) vs 24 hours (IQR 20 – 30)). Rheumatologists reported more consultations for gout per week than GPs: median 4 (IQR 1 – 6.6) vs 1 (IQR 0.2– 1).Rheumatologists scored higher on the BMQ necessity scale, 17.5 (95% CI 16.6 – 18.5) compared to GPs 16.1 (95% CI 15.1 – 17.1). GPs scored higher on BMQ concern scale, 12.1 (95% CI 11.4 – 12.7) compared to rheumatologists, 10.4 (95% CI 9.7 – 11.2). On medication in general, GPs scored higher on both overuse and harms scales compared to rheumatologists, 11.3 (95% CI 10.7 – 12) versus 9.9 (95% CI 9 – 10.7)and 8.3 (95% CI 7.9 – 8.7) vs 7.1 (95% CI 6.5 – 7.7), respectively. Table 1 shows classification according to the BMQ specific for both groups.Table 1.Classification based on the adapted BMQRheumatologists (N=28)GPs (N=45)Acceptant (%)19 (67.9)16 (35.6)Ambivalent (%)08 (17.8)Sceptic (%)1 (3.6)5 (11.1)Indifferent (%)8 (28.6)16 (35.6)Conclusion:For the majority of rheumatologist the necessity beliefs outweighs concern beliefs towards the use of ULT outweighs concern beliefs. GPs show a more heterogenic profile, including acceptant, indifferent and ambivalent beliefs towards ULT use. GPs also show higher harm and overuse concerns regarding medication in general. Next step is to investigate possible associations with actual ULT use and disease outcome.References:[1]Doherty M, et al. Lancet (London, England). 2018;392(10156):1403-12.[2]Reach G. Joint, bone, spine: revue du rhumatisme. 2011;78(5):456-9.[3]Harrold LR et al. Chronic illness. 2010;6(4):263-71.[4]Toelichting BMQ. [updated 2011-12-10; cited 2021-01-28] Available trough: https://meetinstrumentenzorg.nl/instrumenten/beliefs-about-medicine-questionnaire-bmq-bmq-specific-bmq-general/Acknowledgements:This study is sponsored by GrünenthalDisclosure of Interests:Frouwke Veenstra: None declared., Johanna Vriezekolk: None declared., Henk J Schers: None declared., Noortje van Herwaarden: None declared., Bart van den Bemt Speakers bureau: Pfizer, AbbVie, UCB, Biogen and Sandoz, Consultant of: Delivered consultancy work for UCB, Novartis and Pfizer, Grant/research support from: UCB, Pfizer and Abbvie, Marcel Flendrie Consultant of: M. Flendrie has received consultancy fees from Menarini and Grunenthal., Grant/research support from: M. Flendrie has received grants from Menarini and Grunenthal.
4
AlHewiti, Abdullah. "Adherence to Long-Term Therapies and Beliefs about Medications." International Journal of Family Medicine 2014 (February 13, 2014): 1–8. http://dx.doi.org/10.1155/2014/479596.
Full textAbstract:
Objectives. To assess adherence to long-term medications among patients in family medicine clinics and to evaluate relationship between adherence, beliefs about medications, medication information adequacy, and other factors. Methods. Interviewer assisted survey was conducted to assess adherence using the 8-item Morisky Medication Adherence Scale (MMAS-8), beliefs about medications using beliefs about medicine questionnaire (BMQ), and the patients’ perception of medication information adequacy. Results. Of the 408 participants, 56.9% reported low adherence. Pearson’s bivariate correlation showed positive association between MMAS-8 score and BMQ-specific necessity (r=0.526 P<0.001) and the perceived information adequacy (r=0.568 P<0.001), and there was negative association between adherence score and BMQ specific concerns, general overuse, and harm (r=-0.647, -0.466, and -0.663, resp.) (P<0.001). Multivariable analysis revealed that age, number of medications, number of medical conditions, specific necessity and concerns beliefs, general harm beliefs, and perceived adequacy of medication information were independent predictor of adherence. Furthermore, specific beliefs explain 27.7% of the variance in adherence, while medication information adequacy explains 32.3% of the variance in adherence. Conclusion. The prevalence of low adherence among patients on long-term medications is high and it is related to negative beliefs about medications and to inadequate information given to patients about their medications.
5
Wei, Li, Sarah Champman, Xiaomei Li, et al. "Beliefs about medicines and non-adherence in patients with stroke, diabetes mellitus and rheumatoid arthritis: a cross-sectional study in China." BMJ Open 7, no. 10 (2017): e017293. http://dx.doi.org/10.1136/bmjopen-2017-017293.
Full textAbstract:
ObjectivesTo investigate beliefs about medicines and their association with medicine adherence in patients with chronic diseases in China.DesignA cross-sectional questionnaire-based studySettingTwo large urban hospitals in Hefei and Tianjin, ChinaParticipantsHospital inpatients (313 stroke patients) and outpatients (315 diabetic patients and 339 rheumatoid arthritis (RA) patients) were recruited between January 2014 and September 2014.Outcome measuresThe Beliefs about Medicines Questionnaire (BMQ), assessing patients’ beliefs about the specific medicine (Specific-Necessity and Specific-Concerns) prescribed for their conditions (stroke/diabetes/RA) and more general background beliefs about pharmaceuticals as a class of treatment (BMQ-General Benefit, Harm and Overuse); the Perceived Sensitivity to Medicines scale (PSM) assessed patients’ beliefs about how sensitive they were to the effects of medicines and the Medication Adherence Report Scale. The association between non-adherence and beliefs about medicines was assessed using a logistic regression model.ResultsPatients with diabetes mellitus had a stronger perceived need for treatment (mean (SD) Specific-Necessity score, 3.75 (0.40)) than patients with stroke (3.69 (0.53)) and RA (3.66 (0.44)) (p=0.049). Moderate correlations were observed between Specific-Concerns and General-Overuse, General-Harm and PSM (Pearson correlation coefficients, 0.39, 0.49 and 0.49, respectively, p<0.01). Three hundred and eleven patients were non-adherent to their medicine (159 (51.0%) in the stroke group, 60 (26.7%) in the diabetes mellitus group and 62 (19.8%) in the RA group, p<0.01). Across the whole sample, after adjusting for demographic characteristics, non-adherence was associated with patients who had higher concerns about their medicines (OR, 1.35, 95% CI 1.07 to 1.71) and patients who believed that they were personally sensitive to the effects of medications (OR 1.44, 95% CI 1.16 to 1.85).ConclusionThe BMQ is a useful tool to identify patients at risk of non-adherence. In the future, adherence intervention studies may use the BMQ to screen for patients who are at risk of non-adherence and to map interventional support.
6
Tsianos, Epameinondas V., Konstantina Tsianou, Markos G. Tsipouras та ін. "Beliefs about Medicines Questionnaire (BMQ) in inflammatory bowel disease patients in Greece. Ιs this useful?" European Journal for Person Centered Healthcare 4, № 1 (2016): 187. http://dx.doi.org/10.5750/ejpch.v4i1.1067.
Full textAbstract:
Background and Aims: The aim of this study is the revalidation of the Beliefs about Medicine Questionnaire (BMQ) in outpatient gastroenterology clinic patients, in Greece. Methods: A cohort of 163 patients diagnosed with inflammatory bowel disease (IBD), ulcerative colitis (UC) and Crohn’s disease (CD) was included in the study, with the majority of them being in the remission phase. Diagnosis of IBD was established using standard diagnostic criteria. Statistical analysis included descriptive statistics and frequency analysis, Pearson's correlation and analysis of variance (ANOVA). Results: Internal consistency of the BMQ validated with Cronbach's α, being 0.757 in overall and 0.795 and 0.691 for the specific and general parts, respectively. The data adequacy for factor analysis was determined with Kaiser-Meyer-Olkin (KMO) measure > 0.5, while inter-item correlations were found to be significant in all cases. Conclusions: The Greek version of BMQ presented satisfactory psychometric/measurement properties indicating its reliability for use in patients with IBD who receive care in an outpatient hospital clinic.
7
Kadakia, Kunal C., Kelley M. Kidwell, Debra L. Barton, Jennifer J. Griggs, and Norah Lynn Henry. "Examination of factors that influence use of extended adjuvant endocrine therapy (ET)." Journal of Clinical Oncology 35, no. 15_suppl (2017): e21618-e21618. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e21618.
Full textAbstract:
e21618 Background: Extending adjuvant ET from 5 to 10 years has been shown to improve outcomes; however, limited data are known about if and why women pursue extended ET. The primary objective was to estimate the proportion of women who were willing to receive extended ET and secondarily, to determine what factors were associated with this decision. Methods: 133 women on ET for 3-5 years who had not made a decision on extended ET completed a survey about willingness to continue ET, quality-of-life (Functional Assessment of Cancer Therapy-Endocrine Subscale [FACT-ES]), and beliefs about medicines (Beliefs about Medicines Questionnaire Specific [BMQ-S]). BMQ-S assesses patients need for a treatment (necessity beliefs) and concerns about its adverse effects (AEs). The primary outcome, responses to "If in meeting with your doctor, he or she recommends continuing hormonal therapy for longer than 5 years (up to 10 years), how willing ("Not at all" to "Extremely") would you be to continue taking your current hormonal therapy?" was analyzed descriptively. Logistic regression tested for associations between clinical factors (age, stage, chemotherapy), FACT-ES, BMQ-S, and the primary outcome. Results: Most women (112, 85%, 95% confidence interval, CI, 78-91%) were "Moderately" to "Extremely" likely to pursue extended ET. On univariate analysis, younger age (<49 vs ≥50), lower total and social well-being on FACT-ES, and lower necessity and higher concerns on BMQ-S were associated with less willingness to pursue extended ET. Neither stage nor prior chemotherapy was associated with this decision. On multivariable analysis, age and FACT-ES were not associated with this decision (odds ratio, OR 1.03, 95% CI 0.96-1.09, p=0.41; OR 1.01, 95% CI 0.98-1.05, p=0.49). Greater patient perception of necessity of ET compared to concern for AEs was the only independent factor associated with willingness to pursue extended ET (BMQ-S OR 1.34, 95% CI 1.15-1.57, p=0.0005). Conclusions: Most women are likely to purse extended ET if recommended by their physician. Patient decision-making appears to be largely influenced by beliefs of medicines rather than breast cancer-specific clinical factors and should be considered when counseling patients on extended ET.
8
De Castro Parga, M. L., C. Alvarez-Smith, L. Sanroman, et al. "P572 The influence of beliefs about medication in therapeutic adherence among patients with inflammatory bowel disease." Journal of Crohn's and Colitis 15, Supplement_1 (2021): S531. http://dx.doi.org/10.1093/ecco-jcc/jjab076.693.
Full textAbstract:
Abstract Background Medication nonadherence in inflammatory bowel disease (IBD) is common and has a negative impact on disease outcome. It is currently not clear whether in patients with IBD, the opinions, beliefs and attitudes towards medicines determine an adequate therapeutic adherence. Our aim was to assess what the real influence of medication opinions is on IBD patients adherence. Methods Patients attending a tertiary hospital IBD outpatient clinic were enrolled. They filled the BMQ (Beliefs about Medication Questionnaire): a 18-item standardized scale assessing specific opinions about medication that a person is taking and beliefs about the potential for harm and overuse of medication in general. Pharmacy refill data were checked for the previous 3 months and their medication possession ratios (MPR) were calculated. Nonadherence was defined as MPR&lt;0.8.Ethical approval was obtained. Results We analyzed 193 IBD patients: 96 women and 97 men with average age 46.1 years. Ulcerative colitis 109 (56.6%) and 84 Crohn′s disease (43.5%). Oral mesalazine was used for IBD control in 48%, immunosuppressnat in 43.5% and targeted therapies, 28.5%. MPR detected non-adherence in 57 patients (29.5%). Patients with CD had a higher adherence than those with UC (78.6 vs 64.2% p=0.03). Non-adherence was higher in patients with mesalazine 41.3% (p=0.001) and lower with targeted therapies 15% (p=0.007). BMQ classified our IBD patients in 60% “ambivalent”, 36% “accepting”, 7% “indifferent” with no “sceptical”: Females had a higher puntuation in BMQ harm about medication scale (p= 0.006). Surgical patients scored higher about the necessity of their IBD medication (0.005) and patients with a low educational level showed many concerns about IBD medication (0.002). Nevertheless there were neither significant differences in BMQ general (abuse/harm) or specific (need/concern) scores nor in attitude profiles between patients with adequate adherence and non-adherent patients. Conclusion Non-adherence behaviour in IBD patients was not associated with beliefs about medication. Ulcerative colitis and oral mesalazine were related to lower adherence, meanwhile patients on directed therapies showed high adherence,
9
Ilić, Violeta, Dragana Bogićević, Branislava Miljković, and Sandra Vezmar-Kovačević. "Association between Adverse Effects and Parental Beliefs about Antiepileptic Medicines." Medicina 54, no. 4 (2018): 60. http://dx.doi.org/10.3390/medicina54040060.
Full textAbstract:
Background and Aim: Adverse effects are common in children treated with antiepileptic medications and may affect parental beliefs about treatment. The aim of the study was to investigate the relationship between adverse effects and parental beliefs about antiepileptic drugs used for the treatment of their children. Methods: The study was performed at the University Children’s Hospital, Belgrade, Serbia from 2013–2015. Parents of children treated with valproic acid, carbamazepine or lamotrigine, were eligible. They were asked to fill in the Beliefs about Medications Questionnaire (BMQ) and The Liverpool Adverse Events Profile (LAEP). Results: Parents of 127 children (average age 9.88 ± 4.16 years) of whom 111 had epilepsy (67 generalized, 44 focal) and 16 with febrile seizures participated in the study. Nervousness and/or agitation, weight gain, restlessness, headache, difficulty in concentrating, feeling of aggression and upset stomach were most frequent adverse effects, reported in 37% of the population. BMQ-specific necessity scores significantly correlated with parental education; parents with elementary school showed lower scores than those with higher education. The presence of difficulty in concentrating of their child was associated with higher BMQ concern scores (20.73 ± 4.25 vs. 18.99 ± 3.60, p = 0.043) as well as necessity scores (18.42 ± 3.31 vs. 16.40 ± 2.73, p = 0.017). Higher scores of BMQ-general overuse were reported in the presence of a headache (8.79 ± 2.81 vs. 7.64 ± 2.72, p = 0.027). Conclusions: The main finding of our study is that parental beliefs about antiepileptic drugs were associated with the presence of adverse effects. Understanding this relationship could allow physicians and pharmacists to structure better educational programs for parents of children treated with antiepileptic drugs. Education should be more focused towards understanding the adverse effects of antiepileptics which could alleviate parental concerns and strengthen their beliefs about the necessity of medication use in their children.
10
Boruzs, Klára, Viktor Dombrádi, János Sándor, et al. "Cross-Cultural Adaptation and Lingual Validation of the Beliefs about Medicines Questionnaire (BMQ)-Specific for Cholesterol Lowering Drugs in the Visegrad Countries." International Journal of Environmental Research and Public Health 17, no. 20 (2020): 7616. http://dx.doi.org/10.3390/ijerph17207616.
Full textAbstract:
The goal of this study was to translate the Beliefs about Medicines Questionnaire—Specific (BMQ-Specific) for cholesterol-lowering drugs, into the Hungarian, Slovak, Czech and Polish languages and test their reliability with statistical methods. For this purpose, Cronbach’s alpha, confirmatory and exploratory factor analyses were conducted. The analyses included 235 Czech, 205 Hungarian, 200 Polish, and 200 Slovak respondents, all of whom were taking cholesterol-lowering drugs. The translations from English into the target languages were always done by two independent translators. As part of the validation process these translations were pilot tested and after the necessary alterations, they were translated back into English by a third translator. After the approval by the creator of the questionnaire, nationwide surveys were conducted in all four countries. The results of the confirmatory factor analysis were exceptionally good for the Czech and Slovak translations, while the Polish and Hungarian translations marginally crossed the predetermined thresholds. With the exception of a single Polish question, the results of the exploratory factor analysis were deemed acceptable. The translated versions of BMQ-Specific are reliable and valid tools to assess patients’ beliefs about medication, especially medication adherence among patients taking cholesterol-lowering medication. A comparison between the four countries with this questionnaire is now possible.
Dissertations / Theses on the topic "BMQ-Specific"
1
Halilovic, Muratka. "Kranskärlssjuka patienters attityd och följsamhet till läkemedelsbehandling : En kvantitativ undersökning om läkemedelsanvändning." Thesis, Linnéuniversitetet, Institutionen för kemi och biomedicin (KOB), 2015. http://urn.kb.se/resolve?urn=urn:nbn:se:lnu:diva-44024.
Full textAbstract:
Brister i läkemedelsföljsamheten är ett världsomfattande problem. Varannan kroniskt sjuk patient följer inte sin läkemedelsordination. Trots starka bevis på att förebyggande behandlingar efter akut kranskärlssjukdom är effektiva har det i undersökningar visats att följsamheten till dessa mediciner är låg. Låg följsamhet leder till negativa hälsoeffekter; ökade hälso- och sjukvårdskostnader och ökad dödlighet. Syftet med denna studie var att undersöka attityder och följsamhet till läkemedel hos patienter med kranskärlssjukdom. Vidare skulle sambandet mellan olika faktorer hos patienterna och deras attityd och följsamhet till läkemedel undersökas. Studien baserades på enkätundersökningar och ingick som en delstudie i ett större forskningsprojekt ”God läkemedelsanvändning för äldre i Småland (GLAS)”. Till analysen samlades enkäter och journaluppgifter från totalt 91 kranskärlssjuka patienter. Enkäterna var BMQ-Specific (attityd till hjärtläkemedel) och MMAS-8 (följsamhet till kolesterolsänkande läkemedel). Av 91 patienter som deltog var 75 % män. Medelåldern var 69 år (SD = 8,704 år) och genomsnittligt antal regelbundna läkemedel per patient var 7,2 (SD =2,419). En femtedel av patienterna hade stark oro om användningen av förskrivna hjärtläkemedel och 28 % hade bristande följsamhet till kolesterolsänkande läkemedel. De patienter som hade positiv attityd till sin medicin var också de som var mest följsamma. Slutsatser som kan dras av studien är att attityder till läkemedel är en viktig del i hur patienter väljer att följa eller inte följa sin behandlingsregim. Resultaten från studien kan komma att användas till att utveckla insatser för att förbättra patienters läkedelsföljsamhet och behandlingsresultat.<br>God läkemedelsanvändning för äldre i Småland (GLAS)